Rocket Pharmaceuticals Inc’s filing revealed that its insider Militello John unloaded Company’s shares for reported $2301.0 on May 20 ’25. In the deal valued at $6.45 per share,357 shares were sold. As a result of this transaction, Militello John now holds 64,027 shares worth roughly $0.19 million.
Then, Schwartz Jonathan David sold 801 shares, generating $5,163 in total proceeds. Upon selling the shares at $6.45, the insider now owns 235,255 shares.
Before that, Patel Kinnari sold 767 shares. Rocket Pharmaceuticals Inc shares valued at $4,944 were divested by the insider at a price of $6.45 per share. As a result of the transaction, Patel Kinnari now holds 441,927 shares, worth roughly $1.31 million.
Evercore ISI downgraded its Rocket Pharmaceuticals Inc [RCKT] rating to an In-line from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in late May from “an Overweight” to “an Equal-weight”. Leerink Partners also remained covering RCKT and has decreased its forecast on May 28, 2025 with a “Market perform” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on May 28, 2025. It rated RCKT as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of RCKT
On Tuesday, Rocket Pharmaceuticals Inc [NASDAQ:RCKT] saw its stock jump 6.86% to $2.96. Over the last five days, the stock has gained 27.04%. Rocket Pharmaceuticals Inc shares have fallen nearly -76.45% since the year began. Nevertheless, the stocks have fallen -86.20% over the past one year. While a 52-week high of $26.98 was reached on 01/02/25, a 52-week low of $2.19 was recorded on 05/27/25. SMA at 50 days reached $6.20, while 200 days put it at $12.16.
Levels Of Support And Resistance For RCKT Stock
The 24-hour chart illustrates a support level at 2.77, which if violated will result in even more drops to 2.57. On the upside, there is a resistance level at 3.10. A further resistance level may holdings at 3.23. The Relative Strength Index (RSI) on the 14-day chart is 30.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.44%. Stochastics %K at 11.14% indicates the stock is a buying.
How much short interest is there in Rocket Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rocket Pharmaceuticals Inc stocks on 2025-05-15, growing by 0.64 million shares to a total of 13.94 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 13.3 million shares. There was a rise of 4.62%, which implies that there is a positive sentiment for the stock.
